Tanaka, T.; Yoneyama, T.; Noro, D.; Imanishi, K.; Kojima, Y.; Hatakeyama, S.; Tobisawa, Y.; Mori, K.; Yamamoto, H.; Imai, A.;
et al. Aberrant N-Glycosylation Profile of Serum Immunoglobulins is a Diagnostic Biomarker of Urothelial Carcinomas. Int. J. Mol. Sci. 2017, 18, 2632.
https://doi.org/10.3390/ijms18122632
AMA Style
Tanaka T, Yoneyama T, Noro D, Imanishi K, Kojima Y, Hatakeyama S, Tobisawa Y, Mori K, Yamamoto H, Imai A,
et al. Aberrant N-Glycosylation Profile of Serum Immunoglobulins is a Diagnostic Biomarker of Urothelial Carcinomas. International Journal of Molecular Sciences. 2017; 18(12):2632.
https://doi.org/10.3390/ijms18122632
Chicago/Turabian Style
Tanaka, Toshikazu, Tohru Yoneyama, Daisuke Noro, Kengo Imanishi, Yuta Kojima, Shingo Hatakeyama, Yuki Tobisawa, Kazuyuki Mori, Hayato Yamamoto, Atsushi Imai,
and et al. 2017. "Aberrant N-Glycosylation Profile of Serum Immunoglobulins is a Diagnostic Biomarker of Urothelial Carcinomas" International Journal of Molecular Sciences 18, no. 12: 2632.
https://doi.org/10.3390/ijms18122632
APA Style
Tanaka, T., Yoneyama, T., Noro, D., Imanishi, K., Kojima, Y., Hatakeyama, S., Tobisawa, Y., Mori, K., Yamamoto, H., Imai, A., Yoneyama, T., Hashimoto, Y., Koie, T., Tanaka, M., Nishimura, S. -I., Kurauchi, S., Takahashi, I., & Ohyama, C.
(2017). Aberrant N-Glycosylation Profile of Serum Immunoglobulins is a Diagnostic Biomarker of Urothelial Carcinomas. International Journal of Molecular Sciences, 18(12), 2632.
https://doi.org/10.3390/ijms18122632